|
TB-Related Articles
Return to TB-Related Articles
Table of Contents
Journal Articles Published by Division of TB
Elimination (DTBE) Authors
January - December 2005
Butler WR, Floyd MM, Brown JM, Toney SR, Daneshvar
MI, Cooksey RC, Carr J, Steigerwalt AG, Charles N. Novel mycolic
acid-containing bacteria in the family Segniliparaceae fam. nov.,
including the genus Segniliparus gen. nov., with descriptions of
Segniliparus rotundus sp. nov. and Segniliparus rugosus sp. nov.
International Journal of Systematic and Evolutionary Microbiology
2005; 55: 1615-1624.
Bozeman L, Burman W, Metchock B, Welch L, and Weiner
M. Fluoroquinolone susceptibility among Mycobacterium tuberculosis
isolates from the United States
and Canada. Clinical
Infectious Diseases 2005 Feb 1; 40 (3): 386-91.
Burgos M, Gonzalez LC, Paz EA, Gournis E, Kawamura LM, Schecter
G, Hopewell PC, and Daley CL. Treatment of multidrug-resistant tuberculosis
in San Francisco: an outpatient-based approach. Clinical Infectious
Diseases 2005 Apr 1; 40(7): 968-75.
Cowan LS, Diem L, Monson T, Wand P, Temporado D, Oemig TV, and
Crawford JT. Evaluation of a two-step approach for large-scale,
prospective genotyping of Mycobacterium tuberculosis isolates in
the United States. Journal
of Clinical Microbiology 2005 Feb; 43 (2): 688-95.
Dewan P, Sosnovskaja A, Thomsen V, Cicenaite J, Laserson K, Johansen
I, Davidaviciene E, and Wells C. High prevalence of drug-resistant
tuberculosis, Republic of Lithuania, 2002. International Journal
of Tuberculosis and Lung Disease 2005 Feb; 9 (2): 170-4.
Driver CR, Matus SP, Bayuga S, Winters AI, and Munsiff SS. Factors
associated with tuberculosis treatment interruption in New York
City. Journal of Public Health Management and Practice 2005
July/August; 11(4): 361-8.
Frieden TR and Munsiff SS. The DOTS strategy for controlling the
global tuberculosis epidemic. Clinics in Chest Medicine 2005
Jun; 26(2): 197-205.
Granich RM, Oh P, Lewis B, Porco TC, Flood J. Multidrug resistance
among persons with tuberculosis in California, 1994-2003. JAMA 2005
Jun 8; 293(22): 2732-9.
Haddad MB, Wilson TW, Ijaz K, Marks SM, Moore M. Tuberculosis and
homelessness in the United States, 1994–2003. JAMA 2005;
293(22): 2762-2766.
Jasmer RM, Bozeman L, Schwartzman K, Cave MD, Saukkonen JJ, Metchock
B, Khan A, and Burman WJ. Recurrent tuberculosis in the United
States and Canada:
relapse or reinfection? American Journal of Respiratory and Critical
Care Medicine 2004 Dec 15; 170 (12): 1360-6.
Jasmer RM, Seaman CB, Gonzalez LC, Kawamura LM, Osmond DH, Daley
CL. Tuberculosis treatment outcomes: directly observed therapy compared
with self-administered therapy. American Journal of Respiratory
and Critical Care Medicine 2004 Sep 1; 170 (5): 561-6.
Kammerer JS, McNabb SJ, Becerra JE, Rosenblum L, Shang N, Iademarco
MF, and Navin TR. Tuberculosis transmission in nontraditional settings:
a decision-tree approach. American Journal of Preventive Medicine
2005 Feb; 28 (2): 201-7.
Laserson KF, Binkin NJ, Thorpe LE, Laing R, Iademarco MF, Bloom
A, Agerton TB, Nelson L, Cegielski JP, Ferroussier O, Holtz T, Vitek
E, Gammino V, Tan K, Finlay A, Dewan P, Miranda A, Aquino G, Weyer
K, Sy DN, Vernon A, Becerra J, Ershova J, Wells CD. Capacity building
for international tuberculosis control through operations research
training. International Journal of Tuberculosis and Lung Disease
2005; 9(2): 145-150.
Laserson KF, Thorpe LE, Leimane V, Weyer K, Mitnick CD, Riekstina
V, Zarovska E, Rich ML, Fraser HSF, Alarcón, Cegielski JP, Grzemska
M, Gupta R, Espinal M. Speaking the same language: treatment outcome
definitions for multidrug-resistant tuberculosis. International
Journal of Tuberculosis and Lung Disease 2005; 9(6): 640-645.
Laserson KF, Yen NTN, Thornton CG, Mai VTC, Jones W, An DQ, Phuoc
NH, Trinh NA, Nhung DTC, Lien TX, Lan NTN, Wells C, Binkin N, Cetron
M, Maloney SA. Improved sensitivity of sputum smear microscopy after
processing specimens with C18-carboxypropylbetaine to
detect acid-fast bacilli: a study of United States–bound immigrants
from Vietnam. Journal
of Clinical Microbiology 2005 July; 43(7): 3460-3462.
Leimane V, Riekstina V, Holtz TH, Zarovska E, Skripconoka V, Thorpe
LE, Laserson KF, Wells CD. Clinical outcome of individualised treatment
of multidrug-resistant tuberculosis in Latvia:
a retrospective cohort study. Lancet 2005; 365: 318-326.
Levy MZ, Medeiros EA, Shang N, Soares MC, Homenko AS, Almeida RM,
Garrett DO, Roth VR, Jarvis WR, Wells CD, Binkin N, and Laserson
KF. TST reversion in a BCG-revaccinated population of nursing and
medical students, Sao Paulo, Brazil, 1997-2000. International
Journal of Tuberculosis and Lung Disease 2005 Jul; 9 (7): 771-6.
Li J, Munsiff SS, Driver CR, and Sackoff J. Relapse and acquired
rifampin resistance in HIV-infected patients with tuberculosis treated
with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
Clinical Infectious Diseases 2005 Jul 1; 41(1): 83-91.
Lobato MN, Reves RR, Jasmer RM, Grabau JC, Bock NN, Shang N (2RZ
Study Group). Adverse events and treatment completion for latent
tuberculosis in jail inmates and homeless persons. Chest
2005; 127(4): 1296-1303.
LoBue PA and Moser KS. Isoniazid- and rifampin-resistant tuberculosis
in San Diego County, California, United States, 1993-2002. International
Journal of Tuberculosis and Lung Disease 2005 May; 9(5): 501-6.
LoBue PA and Moser KS. Treatment of Mycobacterium bovis–infected
tuberculosis patients: San Diego County, California, United States,
1994-2003. International Journal of Tuberculosis and Lung Disease
2005 Mar; 9 (3): 333-8.
Malakmadze N, Gonzalez IM, Oemig T, Isiadinso I, Rembert D, McCauley
MM, Wand P, Diem L, Cowan L, Palumbo GJ, Fraser M, Ijaz K. Unsuspected
recent transmission of tuberculosis among high-risk groups: implications
of universal tuberculosis enotyping in its detection. Clinical
Infectious Diseases 2005; 40: 366-373.
Maus CE, Plikaytis BB, and Shinnick TM. Molecular analysis of cross-resistance
to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium
tuberculosis. Antimicrobial Agents and Chemotherapy 2005
Aug; 49(8): 3192-3197.
Maus CE, Plikaytis BB, and Shinnick TM. Mutation of tlyA
confers capreomycin resistance in Mycobacterium tuberculosis.
Antimicrob Agents Chemother 2005; 49(2): 571-577.
McElroy PD, Ijaz K, Lambert LA, Jereb JA, Iademarco
MF, Castro KG, Navin TR. National survey to measure rates of liver
injury, hospitalization, and death associated with rifampin and
pyrazinamide for latent tuberculosis infection. Clinical
Infectious Diseases 2005; 41: 1125-1133.
Nelson LJ, Talbot EA, Mwasekaga MJ, Ngirubiu PK, Mwansa RA, Notha
M, Wells CD. Antituberculosis drug resistance and anonymous HIV
surveillance in tuberculosis patients in Botswana,
2002. The Lancet 2005; 366: 488-490.
Pai M, Gokhale K, Joshi R, Dogra S, Kalantri S, Mendiratta DK,
Narang P, Daley CL, Granich RM, Mazurek GH, Reingold AL, Riley LW,
Colford JM. Mycobacterium tuberculosis infection in health care
workers in rural India:
comparison of a whole-blood interferon gamma assay with tuberculin
skin testing. JAMA 2005 Jun 8; 293(22): 2746-55.
Santha T, Garg R, Subramani R, Chandrasekaran V, Selvakumar N,
Sisodia RS, Perumal M, Sinha SK, Singh RJ, Chavan R, Ali F, Sarma
SK, Sharma KM, Jagtap RD, Frieden TR, Fabio L, and Narayanan PR.
Comparison of cough of 2 and 3 weeks to improve detection of smear-positive
tuberculosis cases among out-patients in India. International
Journal of Tuberculosis and Lung Disease 2005 Jan; 9 (1): 61-8.
Schneider E. Tuberculosis Among American Indians and Alaska Natives
in the United States, 1993-2002. American Journal of Public Health
2005; 95(5): 873-880.
Schneider E, Moore M, and Castro KG. Epidemiology of tuberculosis
in the United States. Clinics
in Chest Medicine 2005 Jun;26(2): 183-195.
Selvakumar N, Sivagamasundari S, Prabhakaran E, Govindaraju R,
Perumal M, Granich R, Wares F, Chauhan LS, and Narayanan PR. Storage
of heat-fixed unstained sputum AFB smears for panel testing in a
tuberculosis unit in South India. International Journal of Tuberculosis
and Lung Disease 2005 Feb; 9 (2): 223-5.
Skenders G, Fry AM, Prokopovica I, Greckoseja S, Broka L, Metchock
B, Holtz TH, Wells CD, Leimane V. Multidrug-resistant tuberculosis
detection, Latvia. Emerging Infectious Diseases 2005 Sept;
11(9): 1461-1463.
Tappero JW, Bradford WZ, Agerton TB, Hopewell P, Reingold AL, Lockman
S, Oyewo A, Talbot EA, Kenyon TA, Moeti TL, Moffat HJ, and Peloquin
CA. Serum concentrations of antimycobacterial drugs in patients
with pulmonary tuberculosis in Botswana.
Clinical Infectious Diseases 2005 Aug 15;41(4): 461-9.
Weiner M, Benator D, Burman W, Peloquin CA, Khan A, Vernon A, Jones
B, Silva-Trigo C, Zhao Z, and Hodge T. Association between acquired
rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid
among patients with HIV and tuberculosis. Clinical Infectious
Diseases 2005 May 15;40(10): 1481-91.
Williams BG, Granich R, Chauhan LS, Dharmshaktu NS, Dye C. The
impact of HIV/AIDS on the control of tuberculosis in India.
Proceedings of the National Academy of Sciences of the United
States of America 2005 July 5; 102 (27): 9619-24.
Last Reviewed: 05/18/2008 Content Source: Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
|